{"podcast":{"title":"The Fellow on Call: The Heme/Onc Podcast","slug":"the-fellow-on-call-the-heme-onc-podcast-4669989","podcast_index_feed_id":4669989,"rss_url":"https://www.thefellowoncall.com/tfocpodcast?format=rss","website_url":"https://www.thefellowoncall.com/tfocpodcast/","image_url":"https://images.squarespace-cdn.com/content/v1/61b273ac9be6aa2250498c9e/1641065434990-8BV6L7UFJF4JCCKCY6S1/Untitled+design+%281%29+copy.png?format=1500w","author":"Ronak Mistry","episode_count":164,"summary":"We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.","last_synced_at":"2026-06-24T18:17:58.817010+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989"},"episodes":[{"title":"Episode 156: Immune Thrombocytopenic Purpura Series, Pt 2- Relapsed/Refractory","slug":"episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory","published_at":"2026-06-24T08:00:57+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory","url":"https://www.thefellowoncall.com/tfocpodcast/itprelapsedrefractory","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 155: Immune Thrombocytopenic Purpura Series, Pt 1- First Line Management","slug":"episode-155-immune-thrombocytopenic-purpura-series-pt-1-first-line-management","published_at":"2026-06-17T08:30:29+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-155-immune-thrombocytopenic-purpura-series-pt-1-first-line-management","url":"https://www.thefellowoncall.com/tfocpodcast/itpfirstlinemgmt","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-155-immune-thrombocytopenic-purpura-series-pt-1-first-line-management/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-155-immune-thrombocytopenic-purpura-series-pt-1-first-line-management.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 154: Ask The Program Directors-The Do’s and Don'ts of Applying to Hematology Fellowship (Career Development Series)","slug":"episode-154-ask-the-program-directors-the-do-s-and-don-ts-of-applying-to-hematology-fellowship-career-development-series","published_at":"2026-05-20T08:00:10+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-154-ask-the-program-directors-the-do-s-and-don-ts-of-applying-to-hematology-fellowship-career-development-series","url":"https://www.thefellowoncall.com/tfocpodcast/hematopoeisisepisode2","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-154-ask-the-program-directors-the-do-s-and-don-ts-of-applying-to-hematology-fellowship-career-development-series/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-154-ask-the-program-directors-the-do-s-and-don-ts-of-applying-to-hematology-fellowship-career-development-series.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 153: Myeloma Capstone, Pt 2 - MRD-Guided Therapy, Maintenance, and Relapsed/Refractory Sequencing","slug":"episode-153-myeloma-capstone-pt-2-mrd-guided-therapy-maintenance-and-relapsed-refractory-sequencing","published_at":"2026-04-22T08:00:43+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-153-myeloma-capstone-pt-2-mrd-guided-therapy-maintenance-and-relapsed-refractory-sequencing","url":"https://www.thefellowoncall.com/tfocpodcast/myelomacapstone20262","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-153-myeloma-capstone-pt-2-mrd-guided-therapy-maintenance-and-relapsed-refractory-sequencing/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-153-myeloma-capstone-pt-2-mrd-guided-therapy-maintenance-and-relapsed-refractory-sequencing.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 152: Myeloma Capstone, Pt 1 - Smoldering Myeloma & Frontline Treatment in the Elderly","slug":"episode-152-myeloma-capstone-pt-1-smoldering-myeloma-frontline-treatment-in-the-elderly","published_at":"2026-04-15T08:00:21+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-152-myeloma-capstone-pt-1-smoldering-myeloma-frontline-treatment-in-the-elderly","url":"https://www.thefellowoncall.com/tfocpodcast/myelomacapstone20261","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-152-myeloma-capstone-pt-1-smoldering-myeloma-frontline-treatment-in-the-elderly/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-152-myeloma-capstone-pt-1-smoldering-myeloma-frontline-treatment-in-the-elderly.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 151: Myeloma Series, Pt. 11 - Role of bispecific T-cell engagers for relapsed/refractory multiple myeloma (2026)","slug":"episode-151-myeloma-series-pt-11-role-of-bispecific-t-cell-engagers-for-relapsed-refractory-multiple-myeloma-2026","published_at":"2026-04-08T08:00:12+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-151-myeloma-series-pt-11-role-of-bispecific-t-cell-engagers-for-relapsed-refractory-multiple-myeloma-2026","url":"https://www.thefellowoncall.com/tfocpodcast/myelomabispecifics","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-151-myeloma-series-pt-11-role-of-bispecific-t-cell-engagers-for-relapsed-refractory-multiple-myeloma-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-151-myeloma-series-pt-11-role-of-bispecific-t-cell-engagers-for-relapsed-refractory-multiple-myeloma-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 150: Myeloma Series, Pt. 10 - Role of CAR T for relapsed/refractory multiple myeloma (2026)","slug":"episode-150-myeloma-series-pt-10-role-of-car-t-for-relapsed-refractory-multiple-myeloma-2026","published_at":"2026-04-01T08:00:37+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-150-myeloma-series-pt-10-role-of-car-t-for-relapsed-refractory-multiple-myeloma-2026","url":"https://www.thefellowoncall.com/tfocpodcast/myelomacart","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-150-myeloma-series-pt-10-role-of-car-t-for-relapsed-refractory-multiple-myeloma-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-150-myeloma-series-pt-10-role-of-car-t-for-relapsed-refractory-multiple-myeloma-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 149: Myeloma Series, Pt. 9 - Maintenance for Multiple Myeloma (2026)","slug":"episode-149-myeloma-series-pt-9-maintenance-for-multiple-myeloma-2026","published_at":"2026-03-18T08:00:50+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-149-myeloma-series-pt-9-maintenance-for-multiple-myeloma-2026","url":"https://www.thefellowoncall.com/tfocpodcast/myelomamaint","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-149-myeloma-series-pt-9-maintenance-for-multiple-myeloma-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-149-myeloma-series-pt-9-maintenance-for-multiple-myeloma-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 148: Myeloma Series, Pt. 8- Transplant in Multiple Myeloma (2026)","slug":"episode-148-myeloma-series-pt-8-transplant-in-multiple-myeloma-2026","published_at":"2026-03-12T08:00:02+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-148-myeloma-series-pt-8-transplant-in-multiple-myeloma-2026","url":"https://www.thefellowoncall.com/tfocpodcast/myelomatransplant2026","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-148-myeloma-series-pt-8-transplant-in-multiple-myeloma-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-148-myeloma-series-pt-8-transplant-in-multiple-myeloma-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 147: Myeloma Series, Pt. 7 - Transplant Consolidation for Multiple Myeloma (2026)","slug":"episode-147-myeloma-series-pt-7-transplant-consolidation-for-multiple-myeloma-2026","published_at":"2026-03-11T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-147-myeloma-series-pt-7-transplant-consolidation-for-multiple-myeloma-2026","url":"https://www.thefellowoncall.com/tfocpodcast/myelomatransplantconsolidation","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-147-myeloma-series-pt-7-transplant-consolidation-for-multiple-myeloma-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-147-myeloma-series-pt-7-transplant-consolidation-for-multiple-myeloma-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 146: Career Development Series-Choosing Your Ideal Mentor","slug":"episode-146-career-development-series-choosing-your-ideal-mentor","published_at":"2026-02-25T09:00:40+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-146-career-development-series-choosing-your-ideal-mentor","url":"https://www.thefellowoncall.com/tfocpodcast/hematopoeisisepisode1","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-146-career-development-series-choosing-your-ideal-mentor/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-146-career-development-series-choosing-your-ideal-mentor.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 145: Myeloma Series, Pt. 6 - First line treatment of Multiple Myeloma (2026)","slug":"episode-145-myeloma-series-pt-6-first-line-treatment-of-multiple-myeloma-2026","published_at":"2026-01-21T09:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-145-myeloma-series-pt-6-first-line-treatment-of-multiple-myeloma-2026","url":"https://www.thefellowoncall.com/tfocpodcast/myelomafirstlinetreatment","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-145-myeloma-series-pt-6-first-line-treatment-of-multiple-myeloma-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-145-myeloma-series-pt-6-first-line-treatment-of-multiple-myeloma-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 144: Myeloma Series, Pt. 5 - Myeloma Risk Stratification and Response Criteria (2026)","slug":"episode-144-myeloma-series-pt-5-myeloma-risk-stratification-and-response-criteria-2026","published_at":"2026-01-07T09:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-144-myeloma-series-pt-5-myeloma-risk-stratification-and-response-criteria-2026","url":"https://www.thefellowoncall.com/tfocpodcast/myelomariskstratmrd","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-144-myeloma-series-pt-5-myeloma-risk-stratification-and-response-criteria-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-144-myeloma-series-pt-5-myeloma-risk-stratification-and-response-criteria-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 143: Myeloma Series, Pt. 4 - Myeloma Pharmacology (2025)","slug":"episode-143-myeloma-series-pt-4-myeloma-pharmacology-2025","published_at":"2025-12-30T16:40:16+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-143-myeloma-series-pt-4-myeloma-pharmacology-2025","url":"https://www.thefellowoncall.com/tfocpodcast/myelomapharm25","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-143-myeloma-series-pt-4-myeloma-pharmacology-2025/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-143-myeloma-series-pt-4-myeloma-pharmacology-2025.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 142: Myeloma Series, Pt.3 - Management of Smoldering Multiple Myeloma (2025)","slug":"episode-142-myeloma-series-pt-3-management-of-smoldering-multiple-myeloma-2025","published_at":"2025-12-17T09:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-142-myeloma-series-pt-3-management-of-smoldering-multiple-myeloma-2025","url":"https://www.thefellowoncall.com/tfocpodcast/smolderingmyeloma","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-142-myeloma-series-pt-3-management-of-smoldering-multiple-myeloma-2025/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-142-myeloma-series-pt-3-management-of-smoldering-multiple-myeloma-2025.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 141: Myeloma Series, Pt.2 - Intro to MGUS and Smoldering Myeloma (2025)","slug":"episode-141-myeloma-series-pt-2-intro-to-mgus-and-smoldering-myeloma-2025","published_at":"2025-12-10T09:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-141-myeloma-series-pt-2-intro-to-mgus-and-smoldering-myeloma-2025","url":"https://www.thefellowoncall.com/tfocpodcast/mgusssmintro2025","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-141-myeloma-series-pt-2-intro-to-mgus-and-smoldering-myeloma-2025/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-141-myeloma-series-pt-2-intro-to-mgus-and-smoldering-myeloma-2025.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 140: Myeloma Series, Pt.1 - Intro to Testing and MGUS (2025)","slug":"episode-140-myeloma-series-pt-1-intro-to-testing-and-mgus-2025","published_at":"2025-12-03T09:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-140-myeloma-series-pt-1-intro-to-testing-and-mgus-2025","url":"https://www.thefellowoncall.com/tfocpodcast/mmintroandmgus2025","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-140-myeloma-series-pt-1-intro-to-testing-and-mgus-2025/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-140-myeloma-series-pt-1-intro-to-testing-and-mgus-2025.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)","slug":"episode-139-follicular-lymphoma-series-pt-4-relapsed-refractory-management-cellular-therapy-options","published_at":"2025-09-17T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-139-follicular-lymphoma-series-pt-4-relapsed-refractory-management-cellular-therapy-options","url":"https://www.thefellowoncall.com/tfocpodcast/follicularrelapsedrefractory2","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-139-follicular-lymphoma-series-pt-4-relapsed-refractory-management-cellular-therapy-options/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-139-follicular-lymphoma-series-pt-4-relapsed-refractory-management-cellular-therapy-options.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)","slug":"episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options","published_at":"2025-09-10T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options","url":"https://www.thefellowoncall.com/tfocpodcast/follicularrelapsedrefractory1","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management","slug":"episode-137-follicular-lymphoma-series-pt-2-front-line-management","published_at":"2025-06-25T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-137-follicular-lymphoma-series-pt-2-front-line-management","url":"https://www.thefellowoncall.com/tfocpodcast/follicularfrontline","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-137-follicular-lymphoma-series-pt-2-front-line-management/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-137-follicular-lymphoma-series-pt-2-front-line-management.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 136: Follicular Lymphoma Series, Pt. 1 - Introduction","slug":"episode-136-follicular-lymphoma-series-pt-1-introduction","published_at":"2025-05-21T07:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-136-follicular-lymphoma-series-pt-1-introduction","url":"https://www.thefellowoncall.com/tfocpodcast/follicularintro","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-136-follicular-lymphoma-series-pt-1-introduction/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-136-follicular-lymphoma-series-pt-1-introduction.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 135: VTE Series - Management of Antiphospholipid Antibody Syndrome","slug":"episode-135-vte-series-management-of-antiphospholipid-antibody-syndrome","published_at":"2025-05-07T06:30:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-135-vte-series-management-of-antiphospholipid-antibody-syndrome","url":"https://www.thefellowoncall.com/tfocpodcast/aplsmgmt","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-135-vte-series-management-of-antiphospholipid-antibody-syndrome/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-135-vte-series-management-of-antiphospholipid-antibody-syndrome.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 134: VTE Series - Diagnosis of Antiphospholipid Antibody Syndrome","slug":"episode-134-vte-series-diagnosis-of-antiphospholipid-antibody-syndrome","published_at":"2025-04-23T06:30:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-134-vte-series-diagnosis-of-antiphospholipid-antibody-syndrome","url":"https://www.thefellowoncall.com/tfocpodcast/aplsdiagnosis","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-134-vte-series-diagnosis-of-antiphospholipid-antibody-syndrome/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-134-vte-series-diagnosis-of-antiphospholipid-antibody-syndrome.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 133: VTE Series - Perioperative Anticoagulation Management and Emergent Reversal","slug":"episode-133-vte-series-perioperative-anticoagulation-management-and-emergent-reversal","published_at":"2025-04-09T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-133-vte-series-perioperative-anticoagulation-management-and-emergent-reversal","url":"https://www.thefellowoncall.com/tfocpodcast/vteacperiopreversal","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-133-vte-series-perioperative-anticoagulation-management-and-emergent-reversal/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-133-vte-series-perioperative-anticoagulation-management-and-emergent-reversal.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 132: VTE Series- Approach to Hypercoagulable/Thrombophilia Testing","slug":"episode-132-vte-series-approach-to-hypercoagulable-thrombophilia-testing","published_at":"2025-04-02T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-132-vte-series-approach-to-hypercoagulable-thrombophilia-testing","url":"https://www.thefellowoncall.com/tfocpodcast/vtehypercoag","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-132-vte-series-approach-to-hypercoagulable-thrombophilia-testing/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-132-vte-series-approach-to-hypercoagulable-thrombophilia-testing.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 131: VTE Series-Approach to workup and initial management","slug":"episode-131-vte-series-approach-to-workup-and-initial-management","published_at":"2025-03-26T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-131-vte-series-approach-to-workup-and-initial-management","url":"https://www.thefellowoncall.com/tfocpodcast/vteintro","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-131-vte-series-approach-to-workup-and-initial-management/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-131-vte-series-approach-to-workup-and-initial-management.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Episode 130: Testicular Cancer Series, Pt 4 - Role of Radiation Oncology","slug":"episode-130-testicular-cancer-series-pt-4-role-of-radiation-oncology","published_at":"2025-03-05T07:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-130-testicular-cancer-series-pt-4-role-of-radiation-oncology","url":"https://www.thefellowoncall.com/tfocpodcast/testicularcaradonc","duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-130-testicular-cancer-series-pt-4-role-of-radiation-oncology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-130-testicular-cancer-series-pt-4-role-of-radiation-oncology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}